Hyundai BioLand Co Ltd
KOSDAQ:052260
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ganesh Benzoplast Ltd
NSE:GANESHBE
|
IN |
|
S H Kelkar and Company Ltd
NSE:SHK
|
IN |
|
S
|
Saudi Industrial Export Company SJSC
SAU:4140
|
SA |
Hyundai BioLand Co Ltd
Inventory
Hyundai BioLand Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hyundai BioLand Co Ltd
KOSDAQ:052260
|
Inventory
₩48.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
|
AmorePacific Corp
KRX:090430
|
Inventory
₩480.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Amorepacific Group
KRX:002790
|
Inventory
₩539.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
3%
|
|
|
Cosmax Inc
KRX:192820
|
Inventory
₩270.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Inventory
₩832.4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Inventory
₩324.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
17%
|
CAGR 10-Years
22%
|
|
Hyundai BioLand Co Ltd
Glance View
HYUNDAI BIOLAND Co., Ltd. engages in the manufacture and sale of pharmaceutical and functional products. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2001-05-17. The firm operates its business through four segments. The Cosmetic Raw Material segment produces products such as portulaca extracts, ulmus extracts, crinum extracts, hyaluronic acids and arbutins. The Pharmaceutical Ingredient segment manufactures and sells products such as phellodendron extracts, ampelopsis extracts and gardenia extracts and others. The Ingredients for Health Functional Food segment produces and distributes red ginseng extract powders, seaweed powders, glucosamine powders, black garlic extract powders, dandelion extract powders, green tea extracts and others. The Medical Device segment involves in the provision of medical equipment such as tissue engineering products, comprised of biological wound dressings and collagen, as well as diagnostic kits, comprised of rapid kits, serological kits and mask packs.
See Also
What is Hyundai BioLand Co Ltd's Inventory?
Inventory
48.6B
KRW
Based on the financial report for Dec 31, 2025, Hyundai BioLand Co Ltd's Inventory amounts to 48.6B KRW.
What is Hyundai BioLand Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
6%
Over the last year, the Inventory growth was -15%. The average annual Inventory growth rates for Hyundai BioLand Co Ltd have been 12% over the past three years , 11% over the past five years , and 6% over the past ten years .
